Structural basis for negative regulation of hypoxia-inducible factor-1α by CITED2

被引:173
作者
Freedman, SJ
Sun, ZYJ
Kung, AL
France, DS
Wagner, G
Eck, MJ
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[4] Novartis Pharmaceut Corp, Dept Oncol, E Hanover, NJ 07936 USA
基金
美国国家科学基金会;
关键词
D O I
10.1038/nsb936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of hypoxia-responsive genes is mediated by the heterodimeric transcription factor hypoxia-inducible factor-1 (HIF-1) in complex with the p300/CREB-binding protein (p300/CBP) transcriptional coactivator. The protein CITED2, which binds p300/CBP, is thought to be a negative regulator of HIF-1 transactivation. We show that the CITED2 transactivation domain (TAD) disrupts a complex of the HIF-1alpha C-terminal TAD (C-TAD) and the cysteine-histidine rich 1 (CH1) domain of p300/CBP by binding CH1 with high affinity. The high-resolution solution structure of the CITED2 TAD p300 CH1 complex shows that the CITED2 TAD, like the HIF-1alpha C-TAD, folds on a helical, Zn2+-containing CH1 scaffold. The CITED2 TAD binds a different, more extensive surface of CH1 than does the HIF-1alpha C-TAD. However, a conserved 'LPXL' sequence motif in CITED2 and HIF-1alpha interacts with an overlapping binding site on CH1. Mutation of the LPEL sequence in full-length CITED2 abolishes p300 binding in vivo. These findings reveal that CITED2 regulates HIF-1 by competing for a hot spot on the p300 CH1 domain.
引用
收藏
页码:504 / 512
页数:9
相关论文
共 48 条
[1]   Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator [J].
Bamforth, SD ;
Bragança, J ;
Eloranta, JJ ;
Murdoch, JN ;
Marques, FIR ;
Kranc, KR ;
Farza, H ;
Henderson, DJ ;
Hurst, HC ;
Bhattacharya, S .
NATURE GENETICS, 2001, 29 (04) :469-474
[2]  
BARTELS C, 1995, J BIOMOL NMR, V5, P1
[3]   Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 [J].
Bhattacharya, S ;
Michels, CL ;
Leung, MK ;
Arany, ZP ;
Kung, AL ;
Livingston, DM .
GENES & DEVELOPMENT, 1999, 13 (01) :64-75
[4]   Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 [J].
Bragança, J ;
Swingler, T ;
Marques, FIR ;
Jones, T ;
Eloranta, JJ ;
Hurst, HC ;
Shioda, T ;
Bhattacharya, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8559-8565
[5]   Transcription - Oxygen sensing gets a second wind [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2002, 295 (5556) :807-808
[6]  
Brunger A. T., 1992, SYSTEM XRAY CRYSTALL
[7]   Protein backbone angle restraints from searching a database for chemical shift and sequence homology [J].
Cornilescu, G ;
Delaglio, F ;
Bax, A .
JOURNAL OF BIOMOLECULAR NMR, 1999, 13 (03) :289-302
[8]   Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response [J].
Dames, SA ;
Martinez-Yamout, M ;
De Guzman, RN ;
Dyson, HJ ;
Wright, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5271-5276
[9]   β-catenin:: molecular plasticity and drug design [J].
Daniels, DL ;
Spink, KE ;
Weis, WI .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (11) :672-678
[10]   Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway [J].
Dann, CE ;
Bruick, RK ;
Deisenhofer, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15351-15356